KZA kazia therapeutics limited

"There are challenges but there are also options for funding,...

  1. 1,198 Posts.
    lightbulb Created with Sketch. 937
    "There are challenges but there are also options for funding, potential positive data and a significantly improved SP, (which also brings benefits for funding). The challenges around funding is noted but talking about insolvent trading is a misleading distraction".

    Management will be presently working through the various funding options available to them.

    Expecting further shareholder dilution in 2023, then good data results from DIPG and GBM.

    IMO, we need new funds, expecting an opportunity to participate in a retail capital share raising with options attached.

    Regards.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.